SGLT-2 inhibitors and the risk of infections: A systematic review and meta-analysis of randomized controlled trials
Acta Diabetologica | Mar 07, 2018
Puckrin R, et al. - The effect of sodium–glucose co-transporter 2 (SGLT-2) inhibitors on genitourinary and other infections was determined. A link was demonstrated between SGLT-2 inhibitors with an increased risk of genital tract infections. No correlation existed between SGLT-2 inhibitors and UTIs. Higher doses of dapagliflozin were related to an increased risk of infection.
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
